Clinical correlates of health-related quality of life among opioid-dependent patients

Quality of Life Research

Volumn 20, Issue 8, 2011, Pages 1205-1213

  Heslin, Kevin C ^a   Stein, Judith A ^a   Heinzerling, Keith G ^a   Pan, Deyu ^a   Magladry, Christine ^a   Hays, Ron D ^a  

^a NONE

Author keywords

Models, Structural; Opiate dependence; Quality of Life; Trials, Randomized clinical

Indexed keywords

BUPRENORPHINE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; HOSPITALIZATION; HUMAN; MIDDLE AGED; MULTICENTER STUDY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BODY MASS INDEX; BUPRENORPHINE; HUMANS; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 80053980409     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-011-9858-y     Document Type: Article

References (50)

1. Strain, E. C., & Stitzer, M. L. (2006). The treatment of opioid dependence (1st ed.). Baltimore: Johns Hopkins University Press.
2. PG Miller WR Miller 2009 What should we be aiming for in the treatment of addiction? Addiction 104 5 685 686 19413777 10.1111/j.1360-0443.2009.02608.x
3. Stewart, A. L., Sherbourne, C. D., Hays, R. D., Wells, K. B., Nelson, E. C., Kamberg, C. J., et al. (1992). Summary and discussion of MOS measures. In A. L. Stewart & J. E. Ware (Eds.), Measuring functioning and well-being: The medical outcomes study approach (pp. 345-371). Durham, NC: Duke University Press.
4. Bjorner, J., Fayers, P., & Idler, E. (2004). Self-rated health. In P. Fayers & R. D. Hays (Eds.), Assessing quality of life in clinical trials (pp. 309-324). New York: Oxford University Press.
5. McDowell, I. (2006). Measuring health: A guide to rating scales and questionnaires. New York: Oxford University Press.
6. SR Baker CL Pankhurst PG Robinson 2007 Testing relationships between clinical and non-clinical variables in xerostomia: A structural equation model of oral health-related quality of life Quality of Life Research 16 297 308 17033902 10.1007/s11136-006-9108-x (Pubitemid 46088362)
7. KH Sousa OM Kwok 2006 Putting Wilson and Cleary to the test: Analysis of a HRQOL conceptual model using structural equation modeling Quality of Life Research 15 725 737 16688505 10.1007/s11136-005-3975-4 (Pubitemid 43843980)
8. DJ Vidrine BC Amick ER Gritz RC Arduino 2005 Assessing a conceptual framework of health-related quality of life in a HIV/AIDS population Quality of Life Research 14 923 933 16041890 10.1007/s11136-004-2148-1 (Pubitemid 40685217)
9. NK Janz MR Janevic JA Didge, et al. 2001 Factors influencing quality of life in older women with heart disease Medical Care 39 588 598 11404642 10.1097/00005650-200106000-00007 1:STN:280:DC%2BD3MzjsVykug%3D%3D (Pubitemid 33603644)
10. S Heo DK Moser B Riegel LA Hall N Christman 2005 Testing a published model of health-related quality of life in heart failure Cardiac Failure 11 372 379 15948088 10.1016/j.cardfail.2004.12.001
11. L Wettergren M Björkholm U Axdorph A Langius-Eklöf 2004 Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma Quality of Life Research 13 1369 1379 15503832 10.1023/B:QURE.0000040790.43372.69 1:STN:280:DC%2BD2crjtlSntg%3D%3D (Pubitemid 39221624)
12. SR Baker CL Pankhurst PG Robinson 2007 Testing relationships between clinical and non-clinical variables in xerostomia: A structural equation model of oral health-related quality of life Quality of Life Research 16 297 308 17033902 10.1007/s11136-006-9108-x (Pubitemid 46088362)
13. CF Ryan JM White 1996 Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire Addiction 91 39 45 8822013 10.1111/j.1360-0443.1996.tb03160.x 1:STN:280:DyaK28vhvFansg%3D%3D (Pubitemid 26026809)
14. J Neale 2004 Measuring the health of Scottish drug users Health and Social Care in the Community 12 202 211 19777710 10.1111/j.1365-2524.2004.00489. x (Pubitemid 38888557)
15. TV Perneger F Giner M del Rio A Mino 1998 Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments BMJ 317 13 18 9651260 1:STN:280:DyaK1czhs1WrtQ%3D%3D (Pubitemid 28333818)
16. D Richter B Eikelmann K Berger 2004 Use of the SF-36 in the evaluation of a drug detoxification program Quality of Life Research 13 907 914 15233504 10.1023/B:QURE.0000025589.07313.46 (Pubitemid 39005100)
17. K Freeman 2003 Health and well-being outcomes for drug-dependent offenders on the NSW Drug Court programme Drug and Alcohol Review 22 409 416 14660130 10.1080/09595230310001613921 (Pubitemid 37496014)
18. DE Deering CMA Frampton J Horn JD Sellman SJ Adamson TL Potiki 2004 Health status of clients receiving methadone maintenance treatment using the SF-36 health survey instrument Drug and Alcohol Review 23 273 280 15370006 10.1080/09595230412331289428 (Pubitemid 39305495)
19. O Dalgard A Egeland K Skaug K Vilimas T Steen 2004 Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection Hepatology 39 74 80 14752825 10.1002/hep.20014 (Pubitemid 38461469)
20. SG Kertesz MJ Larson NJ Horton M Winter R Saitz JH Samet 2005 Homeless chronicity and health-related quality of life trajectories among adults with addictions Medical Care 43 574 585 15908852 10.1097/01.mlr.0000163652.91463.b4 (Pubitemid 40847294)
21. C McGregor A Machin JM White 2003 In-patient benzodiazepine withdrawal: Comparison of fixed and symptom-triggered taper methods Drug and Alcohol Review 22 175 180 12850904 10.1080/09595230100100615 (Pubitemid 36814870)
22. PE Millson L Challacombe PJ Villeneuve B Fischer CJ Strike T Myers R Shore S Hopkins S Raftis M Pearson 2004 Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations Canadian Journal of Public Health 95 99 103 (Pubitemid 38578668)
23. EC Costenbader WA Zule CM Coomes 2007 The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection Drug and Alcohol Dependence 89 251 258 17320314 10.1016/j.drugalcdep.2007.01.006 (Pubitemid 46754678)
24. W Ling L Amass S Shoptaw, et al. 2005 A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxication: Findings from the National Institute on Drug Abuse Clinical Trials Network Addiction 100 1090 1100 16042639 10.1111/j.1360-0443.2005.01154.x (Pubitemid 41113602)
25. IB Wilson PD Cleary 1995 Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes JAMA 273 59 65 7996652 10.1001/jama.273.1.59 1:STN:280:DyaK2M%2FovFWgtA%3D%3D
26. PM Bentler JA Stein 1992 Structural equation models in medical research Statistical Methods in Medical Research 1 159 181 1341656 10.1177/ 096228029200100203 1:STN:280:DyaK2c%2FosVClsQ%3D%3D
27. Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey (Vol. 1). Lincoln, RI: QualityMetric, Incorporated.
28. RD Hays GN Marshall EYI Wang CD Sherbourne 1994 Four-year cross-lagged associations between physical and mental health in the Medical Outcomes Study Journal of Consulting and Clinical Psychology 62 441 449 8063971 10.1037/0022-006X.62.3.441 1:STN:280:DyaK2czkt1Gntw%3D%3D (Pubitemid 24198419)
29. L Amass JB Kamien LK Mikulich 2000 Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet Drug and Alcohol Dependence 58 143 152 10669065 10.1016/S0376-8716(99)00074-5 1:CAS:528:DyaK1MXnslymtbc%3D
30. TD Little WA Cunningham G Shahar KF Widaman 2002 To parcel or not to parcel: Exploring the question, weighing the merits Structural Equation Modeling 9 151 173 10.1207/S15328007SEM0902-1
31. K-H Yuan PM Bentler Y Kano 1997 On averaging variables in a confirmatory factor analysis model Behaviormetrika 24 71 83 10.2333/bhmk.24.71 1:CAS:528:DyaK2sXntlGntrg%3D (Pubitemid 127087883)
32. Bandalos, D. L., & Finney, S. J. (2001). Item parceling issues in structural equation modeling. In G. A. Marcoulides (Ed.), New developments and techniques in structural equation modeling (pp. 269-296). Mahwah, NJ: Lawrence Erlbaum & Associates.
33. DR Wesson W Ling 2003 The clinical opiate withdrawal scale (COWS) Journal of Psychoactive Drugs 35 253 259 12924748 10.1080/02791072.2003.10400007 (Pubitemid 36927370)
34. McGahan, P. L., Griffith, J. A., Parente, R., & McLellan, A. T. (1986). Addiction severity index composite scores manual. Philadelphia, PA: Treatment Research Institute.
35. F Søltoft M Hammer N Kragh 2009 The association of body mass index and health-related quality of life in the general population: Data from the 2003 Health Survey of England Quality of Life Research 18 1293 1299 19813103 10.1007/s11136-009-9541-8
36. Bentler, P. M. (2006). EQS 6 structural equations program manual. Encino, CA: Multivariate Software, Inc.
37. L Hu PM Bentler 1999 Cutoff criteria for fit indexes in covariance structural analysis: Conventional criteria versus new alternatives Structural Equation Modeling 6 1 55 10.1080/10705519909540118
38. K-H Yuan PM Bentler 1998 Robust mean and covariance structure analysis British Journal of Mathematical and Statistical Psychology 51 63 88 9670817 10.1111/j.2044-8317.1998.tb00667.x (Pubitemid 128445054)
39. K-H Yuan PM Bentler 1999 On asymptotic distributions of normal theory MLE in covariance structure analysis under some nonnormal distributions Statistics & Probability Letters 42 107 113 10.1016/S0167-7152(98)00171-0
40. C Chou PM Bentler 1990 Model modification in covariance structure modeling: A comparison among likelihood ratio, Lagrange multiplier, and Wald tests Multivariate Behavioral Research 25 115 136 10.1207/s15327906mbr2501-13
41. ME Sobel 1987 Direct and indirect effects in linear structural equation models Sociological Methods & Research 16 155 176 10.1177/ 0049124187016001006
42. JE Ware B Gandek M Kosinski NK Aaronson G Apolone J Brazier, et al. 1998 The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project Journal of Clinical Epidemiology 51 1167 1170 9817134 10.1016/S0895-4356(98) 00108-5 (Pubitemid 28527172)
43. Gowing, L., Ali, R., & White, J. M. (2009). Buprenorphine for the management of opioid withdrawal. Cochrane Database Systematic Review; CD002025.
44. Amato, L., Davoli, M., Minozzi, S., Ali, R., & Ferri, M. (2005). Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Systematic Review; CD003409.
45. Center for Substance Abuse Treatment. Protracted Withdrawal. Substance Abuse Treatment Advisory, Volume 9, Issue 1.
46. Velikova, G., & Wright, P. (2005). Individual patient monitoring. In Fayer P, Hays R, (Eds.) Assessing quality of life in clinical trials. Oxford University Press.
47. SD Keller MS Bayliss JE Ware MA Hsu AM Damiano TF Goss 1997 Comparison of responses to SF-36 health survey questions with one-week and four-week recall periods Health Services Research 32 367 384 9240286 1:STN:280: DyaK2szosVKiug%3D%3D (Pubitemid 27327239)
48. DL Bandalos 2002 The effects of item parceling on goodness-of-fit and parameter estimate bias in structural equation modeling Structural Equation Modeling 9 78 102 10.1207/S15328007SEM0901-5
49. MH Trivedi AJ Rush SR Wisniewski, et al. 2006 Evaluation of outcomes with Citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice American Journal of Psychiatry 163 28 40 16390886 10.1176/appi.ajp.163.1.28
50. SJ Reiser 1993 The era of the patient: Using the experience of illness in shaping the missions of health care JAMA 269 1012 1018 8429582 10.1001/jama.269.8.1012 1:STN:280:DyaK3s7ls1Wisw%3D%3D (Pubitemid 23066639)